Literature DB >> 20974945

Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin system.

Marsida Kallupi1, Nazzareno Cannella, Daina Economidou, Massimo Ubaldi, Barbara Ruggeri, Friedbert Weiss, Maurizio Massi, Juan Marugan, Markus Heilig, Patricia Bonnavion, Luis de Lecea, Roberto Ciccocioppo.   

Abstract

Drug addiction is a chronic relapsing disorder characterized by compulsive drug seeking and use. Environmental conditioning factors are among the major determinants of relapse in abstinent cocaine users. Here we describe a role of the neuropeptide S (NPS) system in regulating relapse. In rats with a history of cocaine self-administration, presentation of stimuli predictive of drug availability reinstates drug seeking, triggering relapse. Intracerebroventricular (ICV) injection of NPS increased conditioned reinstatement of cocaine seeking, whereas peripheral administration of the NPS receptor antagonist SHA 68 reduced it. Manipulation of the NPS receptor system did not modify cocaine self-administration. We also found that ICV NPS administration activates c-Fos expression in hypocretin-1/orexin-A (Hcrt-1/Ox-A) immunoreactive neurons in the lateral hypothalamus (LH) and in the perifornical area (PeF). Of note, intra-LH and intra-PeF administration of NPS increased conditioned reinstatement of cocaine responding, an effect that was selectively blocked with the Hcrt-1/Ox-A receptor selective antagonist SB334867. Finally, results showed that intra-LH injection of the NPS antagonist [D-Cys(tBu) (5)]NPS blocked cue-induced cocaine seeking, indicating a role for this system in the pathophysiology of drug relapse.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20974945      PMCID: PMC2984152          DOI: 10.1073/pnas.1004100107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord.

Authors:  G J Hervieu; J E Cluderay; D C Harrison; J C Roberts; R A Leslie
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

Review 2.  Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity.

Authors:  Angie M Cason; Rachel J Smith; Pouya Tahsili-Fahadan; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Physiol Behav       Date:  2010-03-23

3.  Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior.

Authors:  Benjamin Boutrel; Paul J Kenny; Sheila E Specio; Rémi Martin-Fardon; Athina Markou; George F Koob; Luis de Lecea
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-15       Impact factor: 11.205

4.  Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake.

Authors:  Matilda Bäckberg; Guillaume Hervieu; Shelagh Wilson; Björn Meister
Journal:  Eur J Neurosci       Date:  2002-01       Impact factor: 3.386

5.  Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system.

Authors:  T L Horvath; C Peyron; S Diano; A Ivanov; G Aston-Jones; T S Kilduff; A N van Den Pol
Journal:  J Comp Neurol       Date:  1999-12-13       Impact factor: 3.215

6.  Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area.

Authors:  J Fadel; A Y Deutch
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

7.  Hypocretin (orexin) enhances neuron activity and cell synchrony in developing mouse GFP-expressing locus coeruleus.

Authors:  Anthony N van den Pol; Prabhat K Ghosh; Rong-Jian Liu; Ying Li; George K Aghajanian; Xiao-Bing Gao
Journal:  J Physiol       Date:  2002-05-15       Impact factor: 5.182

8.  Orexin A activates locus coeruleus cell firing and increases arousal in the rat.

Authors:  J J Hagan; R A Leslie; S Patel; M L Evans; T A Wattam; S Holmes; C D Benham; S G Taylor; C Routledge; P Hemmati; R P Munton; T E Ashmeade; A S Shah; J P Hatcher; P D Hatcher; D N Jones; M I Smith; D C Piper; A J Hunter; R A Porter; N Upton
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

9.  A role for lateral hypothalamic orexin neurons in reward seeking.

Authors:  Glenda C Harris; Mathieu Wimmer; Gary Aston-Jones
Journal:  Nature       Date:  2005-08-14       Impact factor: 49.962

10.  Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects.

Authors:  Yan-Ling Xu; Rainer K Reinscheid; Salvador Huitron-Resendiz; Stewart D Clark; Zhiwei Wang; Steven H Lin; Fernando A Brucher; Joanne Zeng; Nga K Ly; Steven J Henriksen; Luis de Lecea; Olivier Civelli
Journal:  Neuron       Date:  2004-08-19       Impact factor: 17.173

View more
  37 in total

1.  Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulation.

Authors:  Stewart D Clark; Terrence P Kenakin; Steven Gertz; Carla Hassler; Elaine A Gay; Tiffany L Langston; Rainer K Reinscheid; Scott P Runyon
Journal:  Neuropharmacology       Date:  2017-03-03       Impact factor: 5.250

Review 2.  A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?

Authors:  Morgan H James; Stephen V Mahler; David E Moorman; Gary Aston-Jones
Journal:  Curr Top Behav Neurosci       Date:  2017

Review 3.  Multiple roles for orexin/hypocretin in addiction.

Authors:  Stephen V Mahler; Rachel J Smith; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

4.  Orexin/hypocretin neuron activation is correlated with alcohol seeking and preference in a topographically specific manner.

Authors:  David E Moorman; Morgan H James; Elisabeth A Kilroy; Gary Aston-Jones
Journal:  Eur J Neurosci       Date:  2016-02-16       Impact factor: 3.386

5.  Identification of neuropeptide S antagonists: structure-activity relationship studies, X-ray crystallography, and in vivo evaluation.

Authors:  Carla Hassler; Yanan Zhang; Brian Gilmour; Tyler Graf; Timothy Fennell; Rodney Snyder; Jeffrey R Deschamps; Rainer K Reinscheid; Celia Garau; Scott P Runyon
Journal:  ACS Chem Neurosci       Date:  2014-07-11       Impact factor: 4.418

Review 6.  Role of cues and contexts on drug-seeking behaviour.

Authors:  Christina J Perry; Isabel Zbukvic; Jee Hyun Kim; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

7.  Central neuropeptide-S administration alleviates stress-induced impairment of gastric motor functions through orexin-A.

Authors:  Mehmet Bülbül; Osman Sinen; Onur Bayramoğlu
Journal:  Turk J Gastroenterol       Date:  2020-01       Impact factor: 1.852

8.  Intraventricular administration of neuropeptide S has reward-like effects.

Authors:  Junran Cao; Luis de Lecea; Satoshi Ikemoto
Journal:  Eur J Pharmacol       Date:  2011-02-22       Impact factor: 4.432

9.  Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction.

Authors:  Marsida Kallupi; Giulia Scuppa; Giordano de Guglielmo; Girolamo Calò; Friedbert Weiss; Michael A Statnick; Linda M Rorick-Kehn; Roberto Ciccocioppo
Journal:  Neuropsychopharmacology       Date:  2016-08-26       Impact factor: 7.853

Review 10.  Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.

Authors:  Jesse R Schank; Andrey E Ryabinin; William J Giardino; Roberto Ciccocioppo; Markus Heilig
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.